Results 221 to 230 of about 146,006 (289)

Signaling pathways and targeted therapy in high‑risk refractory thyroid cancer: From bench to bedside (Review). [PDF]

Int J Oncol
Wang J, Liu Z, Zhang Q, Sun W.
europepmc   +1 more source

Mapping nationally adopted targets for antimicrobial consumption and stewardship indicators in the human health domain, 25 European Union/European Economic Area countries, 2025. [PDF]

Euro Surveill
Högberg LD, Vlahović-Palčevski V, Leung VH, ESAC-Net study group.   +3 more
europepmc   +1 more source

Photon irradiation prompts autophagy in anaplastic thyroid cancer. [PDF]

BMC Cancer
Wächter S, Knauff F, Roth S, Krasser-Gercke N, Roth K, Ebrahimifard A, Bartsch DK, Di Fazio P.   +7 more
europepmc   +1 more source

Mutation-specific dynamics of dedifferentiation trajectories and tumor-stromal interactions in thyroid cancer. [PDF]

Mol Cancer
Joo EH, Song YS, Lee HS, Jung G, Chung EJ, Kim SJ, Kim YH, Cho SW, Choi H, Won JK, Park WY, Park YJ.   +11 more
europepmc   +1 more source

Cell-state transitions and microenvironmental remodeling in thyroid cancer progression revealed by single-cell and spatial transcriptomics. [PDF]

Front Immunol
Wang X, Tao D, Xu J, Liu W, Ji Z, Zhou H, Wang Z.   +6 more
europepmc   +1 more source

Real-world drug use in ATC and ICD-10: an expert-curated drug–diagnosis resource based on UK primary care and Danish hospitalization electronic health records

Louloudis I, Currant H, Ytsma CR, Lindgaard SC, Balaganeshan SB, Haue AD, Pisliakova M, Chen W, Thio S, Brunak S, Denaxas S.   +10 more
europepmc   +1 more source